Viscofan (VIS) - Total Assets
Based on the latest financial reports, Viscofan (VIS) holds total assets worth €1.52 Billion EUR (≈ $1.77 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Viscofan (VIS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Viscofan - Total Assets Trend (2000–2025)
This chart illustrates how Viscofan's total assets have evolved over time, based on quarterly financial data. See Viscofan (VIS) shareholders funds for net asset value and shareholders' equity analysis.
Viscofan - Asset Composition Analysis
Current Asset Composition (December 2025)
Viscofan's total assets of €1.52 Billion consist of 54.2% current assets and 45.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.4% |
| Accounts Receivable | €329.60 Million | 22.9% |
| Inventory | €386.86 Million | 26.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €25.98 Million | 1.8% |
| Goodwill | €13.61 Million | 0.9% |
Asset Composition Trend (2000–2025)
This chart illustrates how Viscofan's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see VIS stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Viscofan's current assets represent 54.2% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, up from 1.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 26.8% of total assets.
Viscofan Competitors by Total Assets
Key competitors of Viscofan based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ball Corporation
NYSE:BALL
|
USA | $19.77 Billion |
|
Taiwan Hon Chuan Enterprise Co Ltd
TW:9939
|
Taiwan | NT$46.80 Billion |
|
Pact Group Holdings Ltd
AU:PGH
|
Australia | AU$2.05 Billion |
|
Nahar Poly Films Limited
NSE:NAHARPOLY
|
India | Rs10.09 Billion |
|
Shin Poong Pap
KO:002870
|
Korea | ₩77.13 Billion |
|
Hindusthan National Glass & Industries Limited
NSE:HINDNATGLS
|
India | Rs29.11 Billion |
|
Sriwahana
JK:SWAT
|
Indonesia | Rp609.27 Billion |
|
Amcor Plc
AU:AMC
|
Australia | AU$37.58 Billion |
Viscofan - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 2.07 | 3.43 |
| Quick Ratio | 0.98 | 1.02 | 1.79 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €417.16 Million | €419.23 Million | €431.80 Million |
Viscofan - Advanced Valuation Insights
This section examines the relationship between Viscofan's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.90 |
| Latest Market Cap to Assets Ratio | 1.87 |
| Asset Growth Rate (YoY) | 2.8% |
| Total Assets | €1.44 Billion |
| Market Capitalization | $2.69 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Viscofan's assets above their book value (1.87x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Viscofan's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Viscofan (2000–2025)
The table below shows the annual total assets of Viscofan from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €1.44 Billion ≈ $1.69 Billion |
+2.76% |
| 2024-12-31 | €1.40 Billion ≈ $1.64 Billion |
-0.33% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
+4.46% |
| 2022-12-31 | €1.35 Billion ≈ $1.58 Billion |
+15.28% |
| 2021-12-31 | €1.17 Billion ≈ $1.37 Billion |
+12.34% |
| 2020-12-31 | €1.04 Billion ≈ $1.22 Billion |
-4.11% |
| 2019-12-31 | €1.09 Billion ≈ $1.27 Billion |
+4.96% |
| 2018-12-31 | €1.03 Billion ≈ $1.21 Billion |
+7.59% |
| 2017-12-31 | €960.80 Million ≈ $1.12 Billion |
+3.20% |
| 2016-12-31 | €930.99 Million ≈ $1.09 Billion |
+11.91% |
| 2015-12-31 | €831.92 Million ≈ $972.60 Million |
-5.13% |
| 2014-12-31 | €876.90 Million ≈ $1.03 Billion |
+10.91% |
| 2013-12-31 | €790.67 Million ≈ $924.38 Million |
+1.69% |
| 2012-12-31 | €777.57 Million ≈ $909.06 Million |
+11.51% |
| 2011-12-31 | €697.30 Million ≈ $815.21 Million |
+1.18% |
| 2010-12-31 | €689.17 Million ≈ $805.71 Million |
+11.88% |
| 2009-12-31 | €615.99 Million ≈ $720.16 Million |
+3.27% |
| 2008-12-31 | €596.47 Million ≈ $697.33 Million |
+5.42% |
| 2007-12-31 | €565.78 Million ≈ $661.46 Million |
+1.19% |
| 2006-12-31 | €559.11 Million ≈ $653.66 Million |
+8.34% |
| 2005-12-31 | €516.06 Million ≈ $603.33 Million |
+17.57% |
| 2004-12-31 | €438.95 Million ≈ $513.18 Million |
+4.37% |
| 2003-12-31 | €420.59 Million ≈ $491.71 Million |
-2.33% |
| 2002-12-31 | €430.60 Million ≈ $503.41 Million |
-11.07% |
| 2001-12-31 | €484.21 Million ≈ $566.09 Million |
-99.41% |
| 2000-12-31 | €81.60 Billion ≈ $95.40 Billion |
-- |
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more